ROYCE & ASSOCIATES LP - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$1,812,768
+16.5%
137,958
+11.7%
0.02%
+20.0%
Q2 2023$1,556,012
+31.8%
123,493
+36.5%
0.02%
+25.0%
Q1 2023$1,180,229
+81.1%
90,439
+144.8%
0.01%
+71.4%
Q4 2022$651,763
+57.1%
36,948
-27.5%
0.01%
+75.0%
Q3 2020$415,000
-86.4%
50,977
-88.7%
0.00%
-88.2%
Q2 2020$3,057,000
-8.9%
451,524
-5.2%
0.03%
-26.1%
Q1 2020$3,355,000
-35.7%
476,524
-10.3%
0.05%
-2.1%
Q4 2019$5,217,000
-20.8%
531,524
-11.3%
0.05%
-23.0%
Q3 2019$6,583,000
-26.9%
599,524
-22.6%
0.06%
-24.7%
Q2 2019$9,008,000
-2.0%
774,524
-19.6%
0.08%
+3.8%
Q1 2019$9,196,000
-38.6%
963,924
-38.0%
0.08%
-41.8%
Q4 2018$14,983,000
-34.4%
1,554,300
-3.1%
0.13%
-15.2%
Q3 2018$22,854,000
+17.9%
1,603,800
-0.7%
0.16%
+17.9%
Q2 2018$19,390,000
+3.9%
1,615,800
+6.9%
0.13%
+2.3%
Q1 2018$18,665,000
-21.3%
1,511,300
-7.3%
0.13%
-17.1%
Q4 2017$23,711,000
+6.1%
1,629,600
+3.8%
0.16%
+6.8%
Q3 2017$22,343,000
-6.4%
1,570,100
-16.1%
0.15%
-6.3%
Q2 2017$23,869,000
-2.6%
1,870,600
-3.3%
0.16%
-1.2%
Q1 2017$24,517,000
+29.1%
1,933,500
+4.0%
0.16%
+31.1%
Q4 2016$18,987,000
-12.4%
1,859,600
+13.0%
0.12%
-14.7%
Q3 2016$21,670,000
+2.4%
1,645,400
-1.3%
0.14%
+2.1%
Q2 2016$21,170,000
-2.5%
1,666,900
+1.4%
0.14%
+2.2%
Q1 2016$21,709,000
-13.8%
1,643,400
+0.3%
0.14%
-8.7%
Q4 2015$25,197,000
+16.8%
1,638,300
-5.9%
0.15%
+31.6%
Q3 2015$21,577,000
-7.0%
1,740,100
+2.6%
0.11%
+16.3%
Q2 2015$23,209,000
+7.3%
1,696,600
-6.2%
0.10%
+19.5%
Q1 2015$21,636,000
+15.3%
1,809,000
+23.1%
0.08%
+26.2%
Q4 2014$18,766,000
+0.3%
1,469,500
+5.4%
0.06%
+3.2%
Q3 2014$18,706,000
+1.9%
1,394,400
+21.9%
0.06%
+14.5%
Q2 2014$18,356,000
+0.5%
1,143,700
+12.9%
0.06%
+1.9%
Q1 2014$18,266,000
-4.9%
1,013,100
-18.4%
0.05%
-1.8%
Q4 2013$19,206,000
+20.8%
1,242,300
+16.2%
0.06%
+17.0%
Q3 2013$15,900,000
+23.3%
1,069,300
+7.3%
0.05%
+17.5%
Q2 2013$12,892,000996,3000.04%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 875,000$13,138,0002.70%
KESTREL INVESTMENT MANAGEMENT CORP 417,400$6,267,0002.63%
SHAPIRO CAPITAL MANAGEMENT LLC 16,933,530$127,255,604,0002.31%
Adirondack Research & Management Inc. 123,148$1,849,0002.19%
Smith, Graham & Co., Investment Advisors, LP 966,216$14,508,0001.18%
Lombard Odier Asset Management (Switzerland) SA 839,521$12,605,0000.84%
HENNESSY ADVISORS INC 946,800$14,216,0000.83%
Waterfront Wealth Inc. 95,403$1,464,0000.74%
Arjuna Capital 84,697$1,272,0000.62%
SummerHaven Investment Management, LLC 62,844$944,0000.58%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders